Links

Marine Pharmacology Links

• Marine drugs ( http://www.mdpi.com/journal/marinedrugs.) is a journal on the research, development and production of drugs from the sea, including marine natural product chemistry: Marine Drugs publishes peer-refereed scientific articles online quarterly and is an open access online journal. More information on the journal can be found at the website shown above.
• PharmaMar ( http://www.pharmamar.com/Default.aspx) is a biopharmaceutical company that discovers and develops marine-based compounds for the treatment of cancer.  PharmaMar is headquartered in Madrid, Spain and is an operating unit of Zeltia, a publicly traded Spanish holding company.
• Harbor Branch Oceanographic Institute, Center for Marine Biomedical and Biotechnology Research , Florida Atlantic University ( http://www.fau.edu/hboi/mbbr/. The primary mission for the Center for Marine Biomedical and Biotechnology Research is to discover marine natural products with utility as medicines or as tools to allow us to better understand the molecular basis of disease.
• ManRos Therapeutics ( http://www.manros-therapeutics.com/en/) is a development-stage pharmaceutical company engaged in the discovery and development of small molecule drugs against severe pathologies, namely solid tumors, leukemia, neurodegenerative disorders (Alzheimer's and Parkinson's diseases), or some renal diseases (including Polycystic Kidney Disease). ManRos Therapeutics was founded by Dr. Laurent Meijer and Pr. Herve Galons. Over the past decades, Dr. Laurent Meijer has gathered a deep knowledge of the cell division cycle mechanisms as well as the characterization of several classes of regulators, mostly protein kinases.
• GlycoMar ( http://www.glycomar.com) is an innovative biotechnology company that discovers and develops anti-inflammatory drugs based upon the glycobiology of marine organisms.  GlycoMar is located near Oban, Scotland.
• BromMarin ( http://www.brommarin.com/) is a spin-off from TU Bergakademie Freiberg (Technical University of Mining and Technology,  http://tu-freiberg.de in Germany with the aim of developing novel methods in marine biotechnology, marine biomaterials science, as well as encouraging research into the marine pharmacology of sponges. We utilize marine sponges of the Verongida order, which are renewable sources of both the pharmacophore Bromotyrosine and chitinous scaffolds. Bromotyrosines are essential ingredients for many synthetic pathways in marine pharmacology and the scaffolds are needed for tissue engineering applications with both human stem cells and chondrocytes. As such, BromMarin simultaneously extracts highly purified bromotyrosine metabolites in addition to the unique tubular chitinous scaffolds, resulting in maximized usage of this renewable marine resource.

Disclaimer and Additional Terms and Conditions of Use

The descriptions set forth above are not intended to be an endorsement and should not be interpreted as an endorsement of any of the referenced pharmaceutical companies or their products. In addition, if any user or visitor to this webpage (hereinafter "You") decides to visit any linked site set forth herein, You do so at your own risk and it is your responsibility to take all protective measures to guard against viruses or other destructive elements.  The linked sites set forth herein are provided solely as a convenience to You and do not constitute an endorsement by Midwestern University or Dr. Mayer of the contents of such sites. You agree that neither Midwestern University nor Dr. Mayer is responsible or liable for any direct or indirect damage or loss caused by or in connection with the use of any content, products or services provided or advertised on a linked site. Midwestern University and Dr. Mayer make no representations or warranties regarding the content, accuracy, or privacy practices of the linked sites set forth herein. If You are concerned about the privacy practices of an outside site, please consult the site's privacy policy.